Discovery of Novel Molecular Mechanisms Underlying the Pathophysiology of Uterine Fibroids and Associated Heavy Menstrual Bleeding.

被引：0

作者：

Wang, Chen-Yi ^{[1
]}

Maritati, Marina ^{[1
]}

Brien, Darragh P. O. Prime ^{[1
]}

Subramaniam, Kavita S. ^{[1
]}

Cribbs, Adam ^{[1
]}

Malzahn, Jessica ^{[1
]}

Zollner, Thomas M. ^{[2
]}

De Leo, Bianca ^{[2
]}

Obendorf, Maik ^{[2
]}

Mueller, Joerg ^{[2
]}

Fritsch, Martin ^{[2
]}

Kessler, Benedikt M. ^{[1
]}

Zondervan, Krina T. ^{[1
]}

Harris, Adrian ^{[1
]}

Becker, Christian M. ^{[1
]}

Oppermann, Udo ^{[1
]}

Philpott, Martin ^{[1
]}

机构：

[1] Univ Oxford, Oxford, England

[2] Bayer AG, Berlin, Germany

来源：

REPRODUCTIVE SCIENCES | 2020年 / 27卷 / SUPPL 1期

关键词：

D O I：

暂无

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

S-032

引用

页码：301A / 301A

页数：1

共 50 条

[31] Ulipristal acetate for the management of large uterine fibroids associated with heavy bleeding: a review
Donnez, Jacques
Courtoy, Guillaume E.
Donnez, Olivier
Dolmans, Marie-Madeleine
REPRODUCTIVE BIOMEDICINE ONLINE, 2018, 37 (02) : 216 - 223
[32] Ulipristal Acetate (Esmya) in the Management of Heavy Menstrual Bleeding Associated with Fibroids: A Case Series
Briggs, Paula
CURRENT WOMENS HEALTH REVIEWS, 2018, 14 (03) : 272 - 280
[33] Elagolix, Estradiol, and Norethindrone Kit (Oriahnn) for the Management of Heavy Menstrual Bleeding Associated with Fibroids
Antoun, Jumana
AMERICAN FAMILY PHYSICIAN, 2021, 103 (08) : 505 - 506
[34] Regular, Irregular and Fibroid Associated Heavy Menstrual Bleeding Have Different Endometrial Molecular Mechanisms
Lockhart, Michelle G.
Olshansky, Moshe
Girling, Jane E.
Hickey, Martha
Rogers, Peter A. W.
REPRODUCTIVE SCIENCES, 2014, 21 (03) : 315A - 316A
[35] Elagolix for the management of heavy menstrual bleeding associated with uterine fibroids: results from a phase 2a proof-of-concept study
Archer, David F.
Stewart, Elizabeth A.
Jain, Rita I.
Feldman, Robert A.
Lukes, Andrea S.
North, Janine D.
Soliman, Ahmed M.
Gao, Jingjing
Ng, Juki W.
Chwalisz, Kristof
FERTILITY AND STERILITY, 2017, 108 (01) : 152 - +
[36] TREATMENT PATTERNS IN WOMEN WITH UTERINE FIBROIDS AND HEAVY MENSTRUAL BLEEDING: RESULTS FROM A LARGE UF CLAIMS DATABASE
McKain, L.
Edsall, K.
Lickert, C.
VALUE IN HEALTH, 2020, 23 : S543 - S543
[37] Elagolix Improves Quality of Life Among Uterine Fibroids Patients With Heavy Menstrual Bleeding in Phase III Trials
Al-Hendy, Ayman
Soliman, Ahmed M.
Wang, Hui
Coyne, Karin
Carr, Bruce R.
OBSTETRICS AND GYNECOLOGY, 2019, 133 : 149S - 149S
[38] Reduction of Heavy Menstrual Bleeding in Women Not Designated as Responders to Elagolix Plus Add Back Therapy for Uterine Fibroids
Stewart, Elizabeth A.
Archer, David F.
Owens, Charlotte D.
Barnhart, Kurt T.
Bradley, Linda D.
Feinberg, Eve C.
Gillispie-Bell, Veronica
Imudia, Anthony N.
Liu, Ran
Kim, Jin Hee
Al-Hendy, Ayman
JOURNAL OF WOMENS HEALTH, 2022, 31 (05) : 698 - 705
[39] Elagolix Reduced Heavy Menstrual Bleeding With Uterine Fibroids: Primary, 6-Month, Phase 3 Results
Schlaff, William
Al-Hendy, Ayman
Barnhart, Kurt
Owens, Charlotte D.
Liu, Ran
Muneyyirci-Delale, Ozgul
OBSTETRICS AND GYNECOLOGY, 2019, 133 : 9S - 9S
[40] EFFECTS OF RELUGOLIX COMBINATION THERAPY ON BONE MINERAL DENSITY THROUGH 2 YEARS IN WOMEN WITH HEAVY MENSTRUAL BLEEDING ASSOCIATED WITH UTERINE FIBROIDS.
McClung, Michael R.
Lukes, Andrea S.
Venturella, Roberta
Santora, Arthur C.
Zhai, Dongmei
Wagman, Rachel B.
Al-Hendy, Ayman
FERTILITY AND STERILITY, 2021, 116 (03) : E13 - E13

← 1 2 3 4 5 →